Dr. Oz Assists as Drug Executive Collapses During Oval Office Announcement
A press conference in the Oval Office was unexpectedly interrupted on Thursday when a pharmaceutical executive collapsed while President Donald Trump was discussing a new agreement with major drug companies aimed at reducing the prices of obesity medications.
The event, held in Washington, focused on a deal with Eli Lilly and Novo Nordisk to expand access and lower costs for their widely used obesity treatments, Zepbound and Wegovy. The incident occurred as Eli Lilly’s CEO, David Ricks, was addressing the media.
“Are you okay? Gordon, are you okay?”
Ricks reportedly said as he noticed the situation unfolding beside him.
The official identified as Gordon Findlay, Novo Nordisk’s global brand director, appeared to faint and collapse to his knees. Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, was seen rushing to assist Findlay while President Trump observed.
Journalists were quickly escorted from the room as medical assistance was provided. Health and Human Services Secretary was also present during the incident.
Approximately thirty minutes later, when the press conference resumed, President Trump offered an update on Findlay’s condition, noting that he was recovering.
Author’s Summary:
During an Oval Office briefing on lowering obesity drug prices, Novo Nordisk’s Gordon Findlay collapsed, prompting Dr. Mehmet Oz to assist before President Trump reassured attendees of his recovery.